Your browser doesn't support javascript.
loading
Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome.
Heremans, Jessica; Garcia-Perez, Josselyn E; Turro, Ernest; Schlenner, Susan M; Casteels, Ingele; Collin, Roxanne; de Zegher, Francis; Greene, Daniel; Humblet-Baron, Stephanie; Lesage, Sylvie; Matthys, Patrick; Penkett, Christopher J; Put, Karen; Stirrups, Kathleen; Thys, Chantal; Van Geet, Chris; Van Nieuwenhove, Erika; Wouters, Carine; Meyts, Isabelle; Freson, Kathleen; Liston, Adrian.
Afiliação
  • Heremans J; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
  • Garcia-Perez JE; VIB Centre for Brain and Disease Research, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Turro E; Department of Hematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom; Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridg
  • Schlenner SM; VIB Centre for Brain and Disease Research, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Casteels I; Division of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
  • Collin R; Department of Immunology-Oncology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • de Zegher F; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Greene D; Department of Hematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hospitals, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Humblet-Baron S; VIB Centre for Brain and Disease Research, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Lesage S; Department of Immunology-Oncology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montreal, Quebec, Canada.
  • Matthys P; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Penkett CJ; Department of Hematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hosp
  • Put K; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Stirrups K; Department of Hematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom; National Institute for Health Research BioResource-Rare Diseases, Cambridge University Hosp
  • Thys C; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
  • Van Geet C; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Van Nieuwenhove E; VIB Centre for Brain and Disease Research, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Wouters C; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Meyts I; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Freson K; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium. Electronic address: kathleen.freson@med.kuleuven.be.
  • Liston A; VIB Centre for Brain and Disease Research, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium. Electronic address: adrian.liston@vib.be.
J Allergy Clin Immunol ; 142(2): 630-646, 2018 08.
Article em En | MEDLINE | ID: mdl-29391254
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteocondrodisplasias / Doenças Retinianas / Plaquetas / Megacariócitos / Linfócitos B / RNA Nuclear Pequeno / Proteína Quinase 1 Ativada por Mitógeno / Deficiência Intelectual Ligada ao Cromossomo X / Células Precursoras de Linfócitos B / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteocondrodisplasias / Doenças Retinianas / Plaquetas / Megacariócitos / Linfócitos B / RNA Nuclear Pequeno / Proteína Quinase 1 Ativada por Mitógeno / Deficiência Intelectual Ligada ao Cromossomo X / Células Precursoras de Linfócitos B / Síndromes de Imunodeficiência Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos